or
forgot password
  • cancer clinical trials in shreveport, LA

  • Effects of HQK-1001 in Patients With Sickle Cell Disease
    LSU Health Sciences Center
    Shreveport, Louisiana 71130-3932
    Sickle Cell Disease, Sickle Cell Anemia, Sickle Cell Disorders, Hemoglobin S Disease, Sickling Disorder Due to Hemoglobin S
    Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer
    For information concerning this clinical site, please contact Nymox at 800-936-9669.
    Shreveport, Louisiana 71106
    Prostate Cancer
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Highland Clinic
    Shreveport, Louisiana 71105
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Effects of Micronutrient (Chromium) Supplementation on Diabetes
    Louisiana State University Health Sciences Center in Shreveport
    Shreveport, Louisiana 71130
    Diabetes Mellitus, Type 1
    Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
    Willis Knighton Cancer Center
    Shreveport, Louisiana 71103
    Cancer
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Brain and Central Nervous System Tumors
    Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Lung Cancer
    Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
    Veterans Affairs Medical Center - Shreveport
    Shreveport, Louisiana 71130
    Breast Cancer
    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Louisiana State University Hospital - Shreveport
    Head and Neck Cancer
    S9630, Medroxyprogesterone in Treating Women With Breast Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Breast Cancer, Endometrial Cancer
    S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Louisiana State University Hospital - Shreveport
    Lung Cancer
    S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Pancreatic Cancer
    Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Breast Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Lymphoma
    Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Pancreatic Cancer
    S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Cervical Cancer
    Combination Chemotherapy in Treating Women With Breast Cancer
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Louisiana State University Hospital - Shreveport
    Breast Cancer
    S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Neuroendocrine Carcinoma of the Skin
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Colorectal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Feist-Weiller Cancer Center at Louisiana State University Health Sciences
    Shreveport, Louisiana 71130-3932
    Melanoma (Skin)
    S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    Louisiana State University Health Sciences Center - Shreveport

    Trial Locations
    Louisiana State University Health Sciences Center - Shreveport
    Veterans Affairs Medical Center - Shreveport
    Malignant Mesothelioma
    S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Louisiana State University Hospital - Shreveport
    Lymphoma
    S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
    Veterans Affairs Medical Center - Shreveport

    Trial Locations
    Veterans Affairs Medical Center - Shreveport
    Louisiana State University Hospital - Shreveport
    Melanoma (Skin)